Understanding Typhoid Disease After Vaccination: a Single Centre, Randomised, Doubleblind, Placebo Controlled Study to Evaluate M01ZH09 in a Healthy Adult Challenge Model, Using Ty21a Vaccine as a Positive Control.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 05 Apr 2017
At a glance
- Drugs Typhoid vaccine (Primary) ; Typhoid-vaccine-Ty21a
- Indications Typhoid
- Focus Therapeutic Use
- 30 Mar 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2018.
- 06 Nov 2015 Planned primary completion date changed from 1 Sep 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov.
- 13 Dec 2013 Accrual to date is 144% according to United Kingdom Clinical Research Network record.